BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Median Sales Estimate At $4.974


The EPS projection of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) for quarter ended 2016-09-30 is $-0.2. Last week, the EPS forecast was $-0.2 against target of $-0.2, a month earlier. Two months ago, this estimate was $-0.2 versus forecast of $-0.2 three months earlier, implying a deviation of 0%.

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 0.

In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 2, 2, and 2, correspondingly.

EPS estimate downgrade for BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) in the preceding 30, 120, 60 and 90 days were 0, 2, 2, and 2, correspondingly.

Earnings Surprises

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) EPS target for the quarter closed 1 was $-0.2, based on 7 recommendations. As reported on 2016-05-05 the EPS was $-0.31. The change was $-0.08, implying a percentage deviation of -34.78%. The projections showed a standard deviation of 0.01.

Quarterly Sales Estimates

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) yearly sales prediction for the fiscal 2016 stands at $5.163 and the median estimate is at $4.974. Almost 4 analysts issued sales target.

Highest sales target is $6.484 while the lowest target is $4.22 showing standard deviation of 0.986%.

As many as 4 analysts have sales targets revised upside while 4 reduced sales estimates, implying a deviation of 0%.

Last month, 4 revised sales number projection on upside while 4 lowered the sales projections, implying a deviation of -4.211%.

A quarter ago, 4 hiked sales target and 4 reduced sales forecast. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced that the deviation in forecast was -16.98%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 9 times, 1 visits today)